Physician profile
Vaqar Ali
NPI 1154379048
$30,225.27
in general payments reported to CMS, 2019-2025
62 companies · $7,720 in 2025
The $7,720 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,823 · 2020: $3,963 · 2021: $2,560 · 2022: $3,533 · 2023: $7,465 · 2024: $3,160 · 2025: $7,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,077 · Consulting Fee: $5,100 · Travel and Lodging: $2,519 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,076.50 |
| Consulting Fee | $5,100.00 |
| Travel and Lodging | $2,519.11 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,650.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,230.84 | 2019-2025 | Acculink, Xact, Mitraclip |
| Endologix LLC | $3,461.86 | 2020-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Bard Peripheral Vascular, INC. | $3,095.76 | 2020-2025 | Venclose Maven Catheter, Rotarexs 6 F X 135 Cm, Venovo |
| Edwards Lifesciences Corporation | $1,507.13 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $1,458.68 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,236.41 | 2019-2023 | Watchman Flx, Wolverine Coronary Cutting Balloon, Rhythmia Mapping System |
| Medtronic, INC. | $947.25 | 2021-2025 | Corevalve Evolut R, Turbohawk, Linq II |
| Amgen INC. | $782.90 | 2020-2025 | Repatha, Repatha |
| Celonova Biosciences, INC. | $618.68 | 2019-2021 | |
| Imperative Care, INC | $543.34 | 2024-2025 | Symphony Catheter, Prodigy Catheter |
| Novartis Pharmaceuticals Corporation | $492.08 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $452.83 | 2022-2025 | Verquvo |
| Medtronic Vascular, INC. | $412.19 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $411.59 | 2020-2025 | Farxiga, Lokelma |
| Siemens Medical Solutions USA, INC. | $408.71 | 2020-2023 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $348.89 | 2022-2025 | Barostim Neo System |
| Shockwave Medical, INC | $348.62 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $345.76 | 2019-2024 | (Dd3) Venous Stent Und, (Ck4) Mcot |
| Opsens INC. | $341.15 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $334.64 | 2021-2025 | Camzyos, Eliquis |
| Angiodynamics, INC. | $287.05 | 2020-2023 | Auryon Laser System 100-120 Vac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.48 | 2021-2025 | Jardiance |
| Avantec Vascular Corporation | $281.36 | 2021-2024 | |
| Cardiovascular Systems INC. | $280.29 | 2019-2022 | |
| Pfizer INC. | $251.39 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $233.16 | 2021-2024 | |
| Penumbra, INC. | $225.21 | 2019-2025 | Indigo System |
| Actelion Pharmaceuticals US, INC. | $193.96 | 2020-2025 | Opsumit, Uptravi, Opsynvi |
| Inspire Medical Systems, INC. | $175.85 | 2021-2024 | Inspire |
| Janssen Pharmaceuticals, INC | $164.14 | 2019-2023 | Xarelto |
| Cook Medical LLC | $132.13 | 2024-2025 | Advance, Zilver Ptx, Rosen |
| W. L. Gore & Associates, INC. | $110.93 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.18 | 2024 | Lifevest |
| Innovation Technologies INC | $58.75 | 2024 | Irrisept |
| Kiniksa Pharmaceuticals International, Plc | $55.35 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $55.05 | 2021-2024 | |
| Amarin Pharma, INC. | $55.02 | 2021 | |
| Jubilant Draximage, INC. | $49.21 | 2025 | Technetium Tc 99m Sestamibi |
| Asahi Intecc USA, INC. | $44.52 | 2022-2024 | Peripheral Vascular |
| Lexicon Pharmaceuticals, INC. | $35.82 | 2023-2024 | Inpefa |
| Tactile Systems Technology INC | $32.92 | 2023-2024 | Entre Plus, Flexitouch Plus |
| United Therapeutics Corporation | $32.35 | 2024 | Tyvaso |
| Alnylam Pharmaceuticals INC. | $30.75 | 2025 | Amvuttra |
| Baxter Healthcare | $30.40 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Kerecis Limited | $29.46 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kestra Medical Technology Services, INC. | $27.08 | 2025 | Assure Wcd |
| Cordis US Corp. | $24.22 | 2024 | Selution Slrpta |
| Novo Nordisk INC | $23.59 | 2025 | Wegovy |
| Celgene Corporation | $23.49 | 2025 | Eliquis |
| Veryan Medical Incorporated | $22.66 | 2021 | |
| Gilead Sciences, INC. | $18.53 | 2021 | |
| Medicomp INC | $18.06 | 2023 | Telepatch Cardiac Monitor |
| Acutus Medical, INC. | $17.06 | 2022 | |
| Irhythm Technologies, INC. | $15.28 | 2022 | |
| Cashflow Solutions, LLC | $13.04 | 2022 | |
| Glaxosmithkline, LLC. | $12.30 | 2022 | |
| Abbvie INC. | $11.76 | 2021 | |
| Chiesi USA, INC. | $11.19 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $6.97 | 2025 | Rhythm Express |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vaqar Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.